AI Driven Service GeminiBio is co-launching aiMOS with Tolemy Bio to optimize cell therapy media using AI and multi-omics data, creating new upsell opportunities for custom media supplements to existing customers and new collaborations.

Regulatory Quality With ISO 13485 certification and FDA Class 1 Medical Device registration aligned to 21 CFR Part 820, GeminiBio offers a strong regulatory footing that appeals to regulated biopharma and contract manufacturers seeking compliant cGMP materials.

AO and AO-Free The dual manufacturing footprint separating animal origin and animal origin free cGMP operations enables serving both AO and AO-free customer needs, facilitating cross-sell of sera and bioprocess liquids across regulatory contexts.

Expanded Capacity Recent facility expansion in West Sacramento enhances manufacturing capacity and supply reliability, supporting larger orders and faster lead times for bioprocess materials and cell culture products.

FBS and Catalog Acquisition of fetal bovine serum rights from Bio-Techne plus a broad catalog of cGMP bioprocess liquids positions GeminiBio to upsell FBS and customized liquids to researchers and manufacturers.